Huang, Leaf

Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer

Liu, L., Wang, Y., Miao, L., Liu, Q., Musetti, S., Li, J., & Huang, L. (2018) · Molecular Therapy

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 373

Nonviral methods for siRNA delivery

Gao, K., & Huang, L. (2009) · Molecular Pharmaceutics

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 244

Non-viral is superior to viral gene delivery

Li, S.-D., & Huang, L. (2007) · Journal of Controlled Release

MicroRNA in disease regulationRNA Interference and Gene Delivery

Cited by 225

Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors

Miao, L., Liu, Q., Lin, C. M., Luo, C., Wang, Y., Liu, L., Yin, W., Hu, S., Kim, W. Y., & Huang, L. (2017) · Cancer Research

Nanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery

Cited by 215

mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma

Wang, Y., Zhang, L., Xu, Z., Miao, L., & Huang, L. (2018) · Molecular Therapy

Immunotherapy and Immune ResponsesRNA Interference and Gene Delivery

Cited by 206

Nanoformulations for combination or cascade anticancer therapy

Miao, L., Guo, S., Lin, C. M., Liu, Q., & Huang, L. (2017) · Advanced Drug Delivery Reviews

Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery Systems

Cited by 178

Nanodrug Delivery Systems Modulate Tumor Vessels to Increase the Enhanced Permeability and Retention Effect

Huang, D., Sun, L., Huang, L., & Chen, Y. (2021) · Journal of Personalized Medicine

Nanoparticle-Based Drug DeliveryAngiogenesis and VEGF in Cancer

Cited by 176

In vivo delivery of RNAi with lipid-based nanoparticles

Huang, L., & Liu, Y. (2011) · Annual Review of Biomedical Engineering

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 174

Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis

Hu, M., Wang, Y., Liu, Z., Yu, Z., Guan, K., Liu, M., Wang, M., Tan, J., & Huang, L. (2021) · Nature Nanotechnology

Liver physiology and pathologyPregnancy-related medical research

Cited by 136

Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma

Yu, Z., Guo, J., Liu, Y., Wang, M., Liu, Z., Gao, Y., & Huang, L. (2022) · Journal of Nanobiotechnology

Hepatocellular Carcinoma Treatment and PrognosisLiver physiology and pathology

Cited by 114

The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1

Xi, Y., Li, Y., Xu, P., Li, S., Liu, Z., Tung, H.-C., Cai, X., Wang, J., Huang, H., Wang, M., et al. (2021) · Science Advances

Liver physiology and pathologyRedox biology and oxidative stress

Cited by 67

Targeting Serous Epithelial Ovarian Cancer with Designer Zinc Finger Transcription Factors

Lara, H., Wang, Y., Beltran, A. S., Juárez-Moreno, K., Yuan, X., Kato, S., Leisewitz, A. V., Cuello Fredes, M., Licea, A. F., Connolly, D. C., et al. (2012) · Journal of Biological Chemistry

RNA Interference and Gene DeliveryOvarian cancer diagnosis and treatment

Cited by 42

Fusobacterium nucleatum carcinogenesis and drug delivery interventions

Chen, Z., & Huang, L. (2024) · Advanced Drug Delivery Reviews

Bacterial Cancer TherapyGut microbiota and health

Cited by 27